Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated S-ketamine infusions for complex regional pain syndrome type I
NL-OMON21045Suspended
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of esketamine and midazolam in Complex Regional Pain Syndrome Type 1 (CRPS-1) (3 arms), sponsored by Leiden University Medical Center. Primary endpoints: Pain intensity and Blinding assessment. Started Nov 2008; status: suspended.
02
Drugs
esketaminemidazolam
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on NL-OMON21045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21045.